BC-22-DS93_10uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=10uM, 4-(2-Cyano-5-ethyl-7,7,10,10-tetramethyl-8,9-dihydronaphtho[2,3-b][1,5]benzodiazepin-12-yl)-2-fluorobenzoic acid, Retinoid RXRalpha Antagonists targeting RXRA (Novartis, 23626229)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/23626229
Similar Terms
Downloads & Tools

Genes

12 genes differentially expressed following the BC-22-DS93_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
MT2A metallothionein 2A 1.64992
MT1E metallothionein 1E 1.07101
CLPTM1L CLPTM1-like 0.269018
MT1X metallothionein 1X 0.201274
SCN4A sodium channel, voltage gated, type IV alpha subunit 0.201274

decreased expression

Symbol Name Standardized Value
SREBF1 sterol regulatory element binding transcription factor 1 -1.38258
LPCAT3 lysophosphatidylcholine acyltransferase 3 -0.723476
SCD stearoyl-CoA desaturase (delta-9-desaturase) -0.683989
DHCR7 7-dehydrocholesterol reductase -0.294843
FASN fatty acid synthase -0.269018
TINAGL1 tubulointerstitial nephritis antigen-like 1 -0.255857
RNF187 ring finger protein 187 -0.255857